Julie M Cunningham

Author PubWeight™ 220.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 2011 8.57
2 Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008 6.10
3 Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002 5.91
4 The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 2002 4.54
5 Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010 4.51
6 A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009 4.38
7 Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 2013 4.35
8 A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 2010 3.86
9 Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 2010 3.49
10 GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet 2013 3.42
11 BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 2003 3.39
12 Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet 2011 3.16
13 Nonparametric tests of association of multiple genes with human disease. Am J Hum Genet 2005 2.87
14 Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007 2.56
15 Caution on pedigree haplotype inference with software that assumes linkage equilibrium. Am J Hum Genet 2002 2.51
16 Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol 2013 2.48
17 Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet 2010 2.37
18 Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009 2.32
19 Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility Loci. Am J Hum Genet 2004 2.31
20 Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 2007 2.31
21 The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res 2011 2.09
22 A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005 1.96
23 Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet 2003 1.96
24 hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology 2004 1.95
25 Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2007 1.92
26 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
27 Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res 2009 1.83
28 Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood 2010 1.79
29 Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun 2013 1.73
30 miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One 2011 1.72
31 Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet 2006 1.70
32 Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res 2009 1.68
33 LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res 2011 1.64
34 ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol 2013 1.61
35 Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 2009 1.59
36 The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg 2005 1.49
37 Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008 1.49
38 Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2007 1.48
39 Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010 1.47
40 Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev 2009 1.43
41 APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res 2013 1.43
42 Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 2008 1.42
43 Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 2009 1.42
44 Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 2002 1.41
45 Human SULT1A1 gene: copy number differences and functional implications. Hum Mol Genet 2006 1.37
46 The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest 2013 1.37
47 Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun 2013 1.36
48 Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS One 2009 1.35
49 Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2006 1.35
50 Inherited determinants of ovarian cancer survival. Clin Cancer Res 2010 1.32
51 Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 2011 1.32
52 Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes. Hum Genet 2010 1.31
53 Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 2012 1.26
54 Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007 1.26
55 Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer Epidemiol Biomarkers Prev 2008 1.26
56 Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007 1.24
57 Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiol Biomarkers Prev 2013 1.22
58 Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest 2005 1.20
59 A rigorous and comprehensive validation: common genetic variations and lung cancer. Cancer Epidemiol Biomarkers Prev 2010 1.18
60 Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet 2011 1.17
61 Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2008 1.17
62 Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiol Biomarkers Prev 2011 1.14
63 Functional and clinical significance of variants localized to 8q24 in colon cancer. Cancer Epidemiol Biomarkers Prev 2009 1.11
64 Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2011 1.11
65 The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study. J Hum Genet 2008 1.10
66 CYP2C19 variation and citalopram response. Pharmacogenet Genomics 2011 1.09
67 Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2010 1.09
68 ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomarkers Prev 2010 1.08
69 Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol 2014 1.06
70 Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiol Biomarkers Prev 2013 1.02
71 Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiol Biomarkers Prev 2009 1.01
72 Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. Am J Kidney Dis 2005 1.01
73 Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. Int J Mol Epidemiol Genet 2011 1.00
74 Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Hum Genet 2013 0.99
75 Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Res 2012 0.98
76 Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Hum Mol Genet 2013 0.97
77 Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol 2007 0.97
78 Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study. PLoS One 2008 0.95
79 Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. BMC Cancer 2012 0.94
80 MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2011 0.94
81 Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer. BMC Cancer 2009 0.93
82 No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet 2003 0.93
83 Genetic polymorphisms associated with carotid artery intima-media thickness and coronary artery calcification in women of the Kronos Early Estrogen Prevention Study. Physiol Genomics 2012 0.93
84 Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One 2012 0.93
85 Inherited variants in regulatory T cell genes and outcome of ovarian cancer. PLoS One 2013 0.93
86 Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiol Biomarkers Prev 2013 0.92
87 Cystic fibrosis transmembrane conductance regulator gene mutation and lung cancer risk. Lung Cancer 2010 0.92
88 Variants in inflammation genes are implicated in risk of lung cancer in never smokers exposed to second-hand smoke. Cancer Discov 2011 0.92
89 Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2010 0.92
90 Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate 2006 0.91
91 Genetic variations in multiple drug action pathways and survival in advanced stage non-small cell lung cancer treated with chemotherapy. Clin Cancer Res 2011 0.91
92 Common variants in PARK loci and related genes and Parkinson's disease. Mov Disord 2010 0.90
93 Pharmacogenomics of antidepressant induced mania: a review and meta-analysis of the serotonin transporter gene (5HTTLPR) association. J Affect Disord 2011 0.90
94 Risk of ovarian cancer and inherited variants in relapse-associated genes. PLoS One 2010 0.90
95 Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord 2009 0.90
96 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
97 ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes Control 2012 0.90
98 Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Hum Genet 2014 0.89
99 Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res 2013 0.89
100 Coffee, caffeine-related genes, and Parkinson's disease: a case-control study. Mov Disord 2008 0.89
101 Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 2008 0.89
102 Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am J Epidemiol 2004 0.89
103 Microsatellite instability in hereditary and sporadic breast cancers. Int J Cancer 2003 0.88
104 Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens. Addict Biol 2010 0.88
105 Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet 2012 0.88
106 Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology 2006 0.88
107 Germline copy number variation and ovarian cancer survival. Front Genet 2012 0.88
108 Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiol Biomarkers Prev 2013 0.88
109 The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX. J Hepatol 2008 0.87
110 Genomic determinants of motor and cognitive outcomes in Parkinson's disease. Parkinsonism Relat Disord 2012 0.87
111 SEPT9 mutations and a conserved 17q25 sequence in sporadic and hereditary brachial plexus neuropathy. Arch Neurol 2009 0.87
112 Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. Twin Res Hum Genet 2010 0.87
113 Mitochondrial genetic polymorphisms do not predict survival in patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2008 0.87
114 A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cancer Epidemiol Biomarkers Prev 2012 0.86
115 Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Mol Carcinog 2010 0.86
116 Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. BMC Med Genomics 2014 0.86
117 Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: an NCCTG-97-24-51 based study. J Thorac Oncol 2009 0.85
118 Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH. Prostate 2005 0.85
119 Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. Cancer Epidemiol Biomarkers Prev 2012 0.85
120 UCHL1 is associated with Parkinson's disease: a case-unaffected sibling and case-unrelated control study. Neurosci Lett 2005 0.85
121 Beta-synuclein gene variants and Parkinson's disease: a preliminary case-control study. Neurosci Lett 2007 0.85
122 Association of the PDYN gene with alcohol dependence and the propensity to drink in negative emotional states. Int J Neuropsychopharmacol 2012 0.85
123 Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform. BMC Med Genomics 2010 0.84
124 Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 2010 0.84
125 Inflammation-related gene variants as risk factors for pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2011 0.84
126 Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila) 2011 0.84
127 Variants in estrogen-related genes and risk of Parkinson's disease. Mov Disord 2011 0.84
128 Single nucleotide polymorphisms associated with abnormal coronary microvascular function. Coron Artery Dis 2014 0.84
129 Replication of genome wide association studies of alcohol dependence: support for association with variation in ADH1C. PLoS One 2013 0.84
130 Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer. Gynecol Oncol 2009 0.84
131 Plasticity of DNA methylation in a nerve injury model of pain. Epigenetics 2015 0.83
132 Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunol Res 2014 0.82
133 Association of GATA4 sequence variation with alcohol dependence. Addict Biol 2012 0.82
134 Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Ann Surg 2013 0.82
135 Gluthatione-S-transferase P1 polymorphism I105V in familial and sporadic prostate cancer. Cancer Genet Cytogenet 2004 0.82
136 Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. Genet Epidemiol 2014 0.82
137 Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? Parkinsonism Relat Disord 2011 0.81
138 Evaluating the influence of quality control decisions and software algorithms on SNP calling for the affymetrix 6.0 SNP array platform. Hum Hered 2011 0.81
139 Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev 2013 0.80
140 CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis. Cancer Immunol Immunother 2013 0.80
141 Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol 2012 0.80
142 Polymorphisms in metabolism/antioxidant genes may mediate the effect of dietary intake on pancreatic cancer risk. Pancreas 2013 0.79
143 Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertil Steril 2010 0.79
144 Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer. Prostate 2003 0.78
145 Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One 2011 0.78
146 FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status. Leuk Lymphoma 2013 0.78
147 Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Arch Neurol 2011 0.78
148 Polymorphic variants in hereditary pancreatic cancer genes are not associated with pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2009 0.78
149 Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Mol Nutr Food Res 2014 0.77
150 Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions. Parkinsonism Relat Disord 2013 0.77
151 Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma. Front Genet 2012 0.76
152 Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population. BMC Med Genet 2010 0.75
153 Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2015 0.75
154 Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011 0.75
155 Association of TNFSF8 polymorphisms with peripheral neutrophil count. Mayo Clin Proc 2011 0.75
156 No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density. Breast Cancer Res 2012 0.75
157 Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome. BMC Med Genomics 2014 0.75
158 Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Mayo Clin Proc 2010 0.75
159 Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. Am J Epidemiol 2016 0.75
160 Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk. Nat Commun 2015 0.75